U
Molecule Holdings Inc. MLCL
CNSX
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

07/31/2023 04/30/2023 01/31/2023 10/31/2022 07/31/2022
Net Income -5.86% 5.54% 53.68% -72.85% 12.96%
Total Depreciation and Amortization 2.15% -0.49% -1.30% -3.53% -1.09%
Total Amortization of Deferred Charges -- -- -- -113.14% --
Total Other Non-Cash Items -98.24% 198.86% -74.19% 1,685.98% -468.97%
Change in Net Operating Assets 1,787.31% -92.01% -64.92% 246.11% -54.69%
Cash from Operations 92.42% -50.40% -185.18% 128.01% -46.78%
Capital Expenditure -- -- -- -100.00% -92.83%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -99.19% -- -- -- --
Cash from Investing -99.19% -- -- -90.00% -92.83%
Total Debt Issued -80.00% -- -- -28.57% 40.00%
Total Debt Repaid -1,675.63% -1.27% 94.06% -1,582.28% 0.00%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 81.72% -196.78%
Cash from Financing -201.56% 1,576.92% 77.15% -236.90% -65.63%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -205.12% 378.90% -889.74% 104.58% -2,690.16%